Faculty Opinions recommendation of Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial.
2015 ◽
Vol 15
(12)
◽
pp. 1398-1408
◽
2016 ◽
Vol 5
(1)
◽
pp. 93-95
2018 ◽
Vol 5
(suppl_1)
◽
pp. S572-S572
◽
1993 ◽
Vol 37
(8)
◽
pp. 1655-1658
◽
2002 ◽
Vol 185
(9)
◽
pp. 1222-1228
◽
1988 ◽
Vol 63
(8)
◽
pp. 986-990
◽